Azuma M - Search Results

1

Direct effects on antigen-presenting cells and T lymphocytes explain the adjuvanticity of a nontoxic cholera toxin mutant.

Yamamoto M, Kiyono H, Yamamoto S, Batanero E, Kweon MN, Otake S, Azuma M, Takeda Y, McGhee JR. Yamamoto M, et al. Among authors: azuma m. J Immunol. 1999 Jun 15;162(12):7015-21. J Immunol. 1999. PMID: 10358143

2

Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses.

Yamamoto M, Kiyono H, Kweon MN, Yamamoto S, Fujihashi K, Kurazono H, Imaoka K, Bluethmann H, Takahashi I, Takeda Y, Azuma M, McGhee JR. Yamamoto M, et al. Among authors: azuma m. J Infect Dis. 2000 Jul;182(1):180-90. doi: 10.1086/315694. Epub 2000 Jun 30. J Infect Dis. 2000. PMID: 10882596

3

Insufficient resistance of trehalose-6,6-dimycolate-treated T-cell receptor delta gene mutant (TCR delta-/-) mice against influenza virus infection.

Hoq MM, Suzutani T, Nakaya K, Yoshida I, Ogasawara M, Takeda Y, Shibaki T, Itohara S, Yamamoto H, Azuma M. Hoq MM, et al. Among authors: azuma m. Microbiol Immunol. 1999;43(5):491-3. doi: 10.1111/j.1348-0421.1999.tb02433.x. Microbiol Immunol. 1999. PMID: 10449256 Free article.

4

Blockade of CTLA-4 signals inhibits Th2-mediated murine chronic graft-versus-host disease by an enhanced expansion of regulatory CD8+ T cells.

Sakurai J, Ohata J, Saito K, Miyajima H, Hirano T, Kohsaka T, Enomoto S, Okumura K, Azuma M. Sakurai J, et al. Among authors: azuma m. J Immunol. 2000 Jan 15;164(2):664-9. doi: 10.4049/jimmunol.164.2.664. J Immunol. 2000. PMID: 10623808

5

Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.

Saegusa K, Ishimaru N, Yanagi K, Haneji N, Nishino M, Azuma M, Saito I, Hayashi Y. Saegusa K, et al. Among authors: azuma m. J Immunol. 2000 Aug 15;165(4):2251-7. doi: 10.4049/jimmunol.165.4.2251. J Immunol. 2000. PMID: 10925313

6

Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.

Ebata T, Mogi S, Hata Y, Fujimoto JI, Yagita H, Okumura K, Azuma M. Ebata T, et al. Among authors: azuma m. Eur J Immunol. 2001 May;31(5):1410-6. doi: 10.1002/1521-4141(200105)31:5<1410::AID-IMMU1410>3.0.CO;2-H. Eur J Immunol. 2001. PMID: 11465097 Free article.

7

Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.

Saegusa K, Ishimaru N, Yanagi K, Haneji N, Nishino M, Azuma M, Saito I, Hayashi Y. Saegusa K, et al. Among authors: azuma m. Clin Exp Immunol. 2000 Feb;119(2):354-60. doi: 10.1046/j.1365-2249.2000.01121.x. Clin Exp Immunol. 2000. PMID: 10632675 Free PMC article.

8

Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.

Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, Abe R, Azuma M. Saito K, et al. Among authors: azuma m. J Immunol. 1998 May 1;160(9):4225-31. J Immunol. 1998. PMID: 9574523

9

Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells.

Fagnoni FF, Takamizawa M, Godfrey WR, Rivas A, Azuma M, Okumura K, Engleman EG. Fagnoni FF, et al. Among authors: azuma m. Immunology. 1995 Jul;85(3):467-74. Immunology. 1995. PMID: 7558137 Free PMC article.

10

Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.

Matsui T, Kurokawa M, Kobata T, Oki S, Azuma M, Tohma S, Inoue T, Yamamoto K, Nishioka K, Kato T. Matsui T, et al. Among authors: azuma m. J Immunol. 1999 Apr 1;162(7):4328-35. J Immunol. 1999. PMID: 10201965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,398 results

Search Page

Filters